Spots Global Cancer Trial Database for Comparison of Postoperative Recovery of Sevoflurane and Propofol After Transsphenoidal Surgery
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Comparison of Postoperative Recovery of Sevoflurane and Propofol After Transsphenoidal Surgery
Official Title: A Prospective, Randomized Controlled Study to Compare the Effect of Sevoflurane and Propofol for Maintenance of Anesthesia on Postoperative Recovery After Transsphenoidal Resection of Pituitary Adenoma
Study ID: NCT05822817
Conditions
Study Description
Brief Summary: Currently, total intravenous anesthesia (TIVA) and inhaled anesthesia are both commonly used for transsphenoidal pituitary adenoma resection. However, optimal choice for anesthesia maintenance in transsphenoidal surgery remains unclear. Previous studies focusing on this question provided fragmentary assessment and controversial results. The goal of this clinical trial is to investigate whether propofol and sevoflurane have different effect on post-anesthetic recovery after transsphenoidal resection of pituitary adenoma.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Peking Union Medical College Hospital, Beijing, Beijing, China
Contact Details
Name: Yuguang Huang, MD
Affiliation: Department of Anesthesiology, Peking Union Medical College Hospital
Role: STUDY_CHAIR
Name: Lulu Ma, MD
Affiliation: Department of Anesthesiology, Peking Union Medical College Hospital
Role: STUDY_DIRECTOR
Name: Bing Xing, MD
Affiliation: Department of Neurosurgery, Peking Union Medical College Hospital
Role: PRINCIPAL_INVESTIGATOR
Name: Wei Lian, MD
Affiliation: Department of Neurosurgery, Peking Union Medical College Hospital
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
